Acute Flaccid Myelitis: Symptoms, Causes and Treatment

Recognizing a Serious Neurological Threat: The Basics of Acute Flaccid Myelitis

Acute flaccid myelitis, commonly referred to as AFM, represents a rare but potentially serious neurological condition that primarily affects the nervous system’s ability to control muscle function. This condition specifically targets the motor neurons located within the spinal cord, particularly in the gray matter region known as the anterior horn. While AFM remains uncommon, its sudden onset and potentially serious consequences make it important for parents and caregivers to understand its characteristics and recognize early warning signs.

The condition earned the nickname “polio-like syndrome” because its presentation resembles polio in several ways, though AFM is fundamentally different from the poliovirus infection. Most commonly, AFM affects children and young people under the age of 21, though cases have occasionally been documented in immunocompromised adults. The first documented case of AFM in the United States occurred in California during 2012, and since then, medical professionals have worked to better understand this mysterious condition.

The Typical Warning Pattern: How AFM Usually Develops

Understanding the progression of AFM can help parents identify when their child might need medical attention. In most cases, children with AFM experience a characteristic pattern of illness that unfolds over several weeks. The condition typically begins with symptoms that seem relatively ordinary and benign.

Most children diagnosed with AFM show signs of a mild respiratory infection or general fever approximately one to two weeks before neurological symptoms appear. This initial illness might resemble a common cold, with symptoms such as:

• Nasal congestion and rhinorrhea
• Coughing
• General malaise and body aches
• Low-grade fever
• Mild gastrointestinal symptoms including nausea or diarrhea

During this initial phase, parents typically wouldn’t suspect anything more serious than a routine viral infection. However, after the respiratory symptoms begin to resolve or just as the child seems to be recovering, neurological symptoms can emerge rapidly and dramatically. This sudden shift in symptom presentation marks the critical transition from what appeared to be a minor illness to a serious neurological emergency.

Identifying the Hallmark Symptoms of AFM

The defining characteristic of AFM is the sudden onset of muscle weakness that develops over just a few hours to several days. This rapid progression distinguishes AFM from many other neurological conditions that typically develop more gradually. The weakness predominantly affects the limbs but can vary significantly in its distribution and severity from one patient to another.

The primary symptoms that define AFM include:

• Acute limb weakness affecting one or more arms and legs, with weakness typically more pronounced in the upper limbs and proximal muscles
• Loss of muscle tone causing affected limbs to feel floppy or limp
• Diminished or absent reflexes in the affected areas
• Difficulty with coordination and balance as muscle control becomes compromised

Beyond the primary symptoms of limb weakness, children may experience additional neurological complications depending on which areas of the spinal cord and brainstem are affected. These secondary symptoms can include facial drooping or weakness, difficulty moving the eyes in certain directions, drooping eyelids that may impair vision, challenges with swallowing food or liquids, and slurred or unclear speech patterns. Some children also report pain in their affected limbs, back, or neck regions.

A particularly concerning symptom involves difficulty with urination or complete inability to urinate, which suggests involvement of nerve pathways controlling bladder function. In the most severe cases, AFM can affect the muscles responsible for breathing, leading to respiratory failure that requires immediate ventilator support to sustain life.

Understanding the Suspected Viral Connection

While researchers have not definitively identified a single causative agent for AFM, substantial evidence points toward viral infections as the primary trigger. Enteroviruses, a diverse family of viruses that commonly infect humans, have emerged as the leading suspects in AFM cases. These viruses spread through respiratory droplets and fecal-oral routes, making them relatively common in the general population.

Enterovirus D68 has received particular attention from researchers studying AFM. This specific enterovirus typically causes respiratory illness and demonstrates a seasonal pattern in the United States, circulating predominantly during summer and fall months, often in an every-other-year cycle. Enterovirus A71 has also been implicated in numerous AFM cases, particularly in international contexts.

Beyond enteroviruses, researchers have documented associations between AFM and several other viral pathogens, including:

• Flaviviruses such as West Nile virus and Japanese encephalitis virus
• Herpesviruses including herpes simplex virus
• Adenoviruses

The prevailing theory suggests that these viral infections trigger an inflammatory cascade within the nervous system. The immune system’s response to the viral invasion, while intended to fight the infection, inadvertently damages the motor neurons in the spinal cord. This inflammatory-mediated damage disrupts the neurons’ ability to transmit signals to muscles, resulting in the characteristic paralysis observed in AFM.

How Medical Professionals Diagnose AFM

Diagnosing AFM requires a combination of clinical evaluation, laboratory testing, and advanced imaging studies. Because AFM remains relatively rare, some healthcare providers may initially consider other diagnoses, which can sometimes delay recognition of the condition. However, the distinctive pattern of acute weakness following respiratory illness provides important diagnostic clues.

Clinicians begin the diagnostic process by obtaining a detailed history of the child’s recent illnesses and carefully examining neurological function. The physical examination focuses on identifying patterns of muscle weakness, testing reflexes, and assessing cranial nerve function.

Laboratory evaluation typically includes analysis of cerebrospinal fluid obtained through lumbar puncture. In AFM cases, this fluid characteristically shows lymphocytic pleocytosis, meaning an elevated number of white blood cells, particularly lymphocytes. The protein levels in the cerebrospinal fluid are also typically elevated, reflecting inflammation in the nervous system.

Magnetic resonance imaging of the spinal cord provides crucial diagnostic information. The radiological hallmark of AFM involves identifying focal lesions specifically located in the anterior horn of the spinal cord. These lesions typically appear as T2 hyperintense signals on MRI sequences, meaning they appear bright on these specific imaging views. In many AFM patients, the signal abnormalities extend throughout multiple levels of the spinal cord, and surrounding edema may be visible in acute cases.

Electrophysiological testing through electromyography and nerve conduction studies can reveal patterns consistent with motor neuronopathy or axonal neuropathy, further supporting the diagnosis and helping to characterize the extent of nerve damage.

Treatment Approaches and Management Strategies

Currently, no specific antiviral treatment has proven effective for AFM, as the condition appears to result primarily from immune-mediated damage rather than active viral replication in the nervous system. Treatment therefore focuses on supportive care and managing symptoms as the body’s inflammatory response gradually resolves.

Hospitalization becomes necessary for most AFM cases, particularly when children develop significant weakness or respiratory compromise. Medical teams monitor respiratory function closely, and children showing signs of respiratory muscle weakness receive mechanical ventilation support. Some patients may require intubation and intensive care unit admission if breathing becomes severely compromised.

Beyond respiratory support, treatment includes:

• Careful monitoring of vital signs and neurological status
• Management of pain through appropriate analgesic medications
• Physical and occupational therapy to maintain muscle function and prevent complications
• Assistance with activities of daily living for children with significant paralysis
• Catheterization if urinary dysfunction develops
• Nutritional support, particularly if swallowing difficulties occur

Some medical centers have explored immunomodulatory treatments such as intravenous immunoglobulin or plasma exchange based on theoretical rationales, though robust evidence supporting these interventions remains limited. Corticosteroids have been used in some cases to reduce inflammation, but their benefit has not been definitively established through controlled clinical trials.

The Prognosis and Long-Term Outlook for AFM Patients

Understanding what to expect following an AFM diagnosis represents an important concern for families facing this condition. The long-term prognosis for AFM varies considerably among affected individuals, and researchers continue studying outcomes as more cases accumulate and are carefully documented.

The extent of recovery depends on several factors, including the severity of initial paralysis, the extent of spinal cord involvement demonstrated on imaging, and the specific areas of the spinal cord affected. Some children experience substantial recovery over weeks to months, potentially regaining significant motor function. Others face more persistent deficits that may include permanent weakness or paralysis in affected limbs.

Rehabilitation efforts play a crucial role in maximizing functional recovery. Physical therapy helps children regain strength and motor control as nerve healing progresses. Occupational therapy addresses challenges with daily activities and works toward independence. Psychological support helps both children and families adapt to any residual disability.

Current Prevention and Risk Reduction Considerations

Given that viral infections appear to trigger AFM, general infection prevention measures may reduce the risk of exposure to suspected causative viruses. Standard hygiene practices including regular handwashing, respiratory etiquette when coughing or sneezing, and avoiding close contact with individuals showing respiratory symptoms remain important year-round. During seasons when enteroviruses circulate more actively, families might consider heightened vigilance regarding these preventive measures.

Currently, no vaccine specifically prevents AFM. However, maintaining up-to-date immunizations for other preventable diseases remains important for overall health. Some of the viruses suspected of triggering AFM circulate globally, and international travel can increase exposure risk, particularly for individuals traveling to regions where certain flaviviruses or other implicated viruses are endemic.

Frequently Asked Questions About Acute Flaccid Myelitis